Clinical Cardiology Alert – November 1, 2004
November 1, 2004
View Issues
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: The FDA and Merck Fielding Concerns About Vioxx
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market. -
Chronic Kidney Disease
During the last few years, chronic kidney disease has been increasingly recognized as a significant risk factor for the development of cardiovascular disease. An American Heart Association Scientific Statement reviewing this subject was published last fall. -
Atrial Tachyarrhythmias Following Atrial Fibrillation Ablation
Focal left atrial tachycardias are an important complication after pulmonary vein isolation. -
Systemic Vascular Resistance By Echo Doppler
Doppler echocardiography can estimate SVR, and is particularly accurate at identifying a low SVR. -
Constriction vs Restriction Revisited
Tissue Doppler echocardiography can distinguish between constrictive pericarditis and restrictive cardiomyopathy. -
Antibiotics and Sudden Cardiac Death
Patients who use both erythromycin and CYP3A inhibitors, particularly calcium channel blockers, had an increased risk of sudden death from cardiac causes. -
Painless Aortic Dissection
Patients with painless acute aortic dissection are more likely to present with syncope, congestive heart failure or stroke, and have a higher mortality, especially with type B dissection.